Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.360 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

23 24 Next >

What's Going On With Iovance Biotherapeutics Stock? ↗

February 20, 2024

Iovance Biotherapeutics announced Tuesday that the U.S. Food and Drug Administration (FDA) approved the company to begin analytical testing and manufacturing of AMTAGVI at its Philadelphia site....

Via Benzinga

Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 20, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

February 20, 2024

Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Is Iovance Biotherapeutics Stock a Buy Now? ↗

February 08, 2024

It will take a while for its risks to resolve.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Is Crashing Today ↗

December 27, 2023

One of the small biotech's top pipeline programs ran into a major setback.

Via The Motley Fool

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 20, 2024

Pre-market stock movers are a hot topic on Tuesday morning as we start the day with a breakdown of all the latest stock market news!

Via InvestorPlace

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

February 20, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 19, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 19, 2024

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 16, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

February 16, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

February 16, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk ↗

February 12, 2024

The potential pitfall could be dire, but the odds seem to be in the biotech's favor.

Via The Motley Fool

Is Iovance Biotherapeutics a Buy Before This Key FDA Decision? ↗

February 07, 2024

Iovance shares have dropped by double digits over the past three years.

Via The Motley Fool

A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist ↗

February 05, 2024

These biotech innovators have what it takes to soar.

Via The Motley Fool

What's Next for Iovance Biotherapeutics Stock? ↗

February 04, 2024

Focusing on its clinical trial setback could mean missing the bigger picture.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

January 19, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street ↗

January 08, 2024

Find out why investment bank analysts are hyperbullish for these stocks.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Popped Today ↗

December 28, 2023

Iovance rebounded nicely after yesterday's drop, which came after the FDA put a clinical hold on its cancer-therapy trial.

Via The Motley Fool

What's Going On With Bone Biologics Corp Stock? ↗

December 28, 2023

Bone Biologics Corp (NASDAQ: BBLG) shares are trading higher Thursday and has been halted multiple times despite a lack of company-specific news. Here's what you need to know.

Via Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

Investor Sentiment Edges Lower; Dow Jumps Over 100 Points ↗

December 28, 2023

The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Wednesday. U.S. stocks closed higher on Wednesday, with the Dow...

Via Benzinga

Topics Stocks

Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher ↗

December 27, 2023

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...

Via Benzinga

Topics Stocks

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 27, 2023

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 27, 2023

Via Benzinga

Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December ↗

December 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...

Via Benzinga

Topics Economy Stocks

Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday ↗

December 27, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Via Benzinga

Topics Stocks

FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death ↗

December 27, 2023

Wednesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced a clinical program update for LN-145 TIL therapy in non-

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.